Chemical synthesis of a new drug family to treat glioblastoma multiforme (GBM), the highest global unmet need in oncology

Project Information

chemGLIO

Grant agreement ID: 101000160

DOI 10.3030/101000160

Project closed

EC signature date 28 August 2020

Start date 1 November 2020

End date 31 October 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 0,00

EU contribution € 119 035,00

Coordinated by

HEMISPHERIAN AS
Norway